AstraZeneca’s West Chester Twp. site employs approximately 400 people. The company employs nearly 13,000 people nationwide and more than 70,000 worldwide.
MORE: Small businesses need grit, creativity and cash to survive coronavirus
The drug maker said May 21 it had secured its first agreements for 400 million doses of a COVID-19 vaccine it is testing.
The Anglo-Swedish company reported it had received more than $1 billion from the U.S. Biomedical Advanced Research and Development Authority for the development, production and delivery of the vaccine, starting this fall.
MORE: Crowd stays peaceful as Cincinnati protesters join West Chester event
The investment will accelerate the development and production of the vaccine, AstraZeneca CEO Pascal Soriot said. It had already joined forces with the British government and is in discussions with the Serum Institute of India and other potential partners to increase production and distribution.
“We will do everything in our power to make this vaccine quickly and widely available,” Soriot said.
The Associated Press contributed to this report.